Overland Park, Ks., USA - September 10, 2014, Overland Park, Ks., USA - Parnell Pharmaceuticals Holdings Ltd announced that it had appointed Phyllis Gardner and David L. Greenwood to its board of directors
Article continues below
Dr. Gardner has more than 35 years of experience in academia, medicine and the healthcare industry. Dr. Gardner is a prominent researcher in cell biology, pharmacology and gene therapy responsible for more than 75 peer-reviewed publications and numerous patents.
She is a member of the Board of Directors of NASDAQ-listed Revance Therapeutics and Corium International, and was Adjunct Partner (1999-2008); Partner (2009-2014), of Essex Woodlands Health Ventures where she oversaw many successful investments in emerging growth life-sciences companies.
In addition to her acumen and experience in supporting the growth of life-sciences companies, Dr. Gardner has been recognized for her achievements in both academia and scientific research as the recipient of multiple national awards and honors.
She is a tenured Professor of Medicine and a former Senior Associate Dean for Education and Student Affairs at Stanford University School of Medicine, Stanford CA. She is a member of the Harvard Medical School Board of Fellows and the Academic Advisory Council of Education for Harvard Medical School.
Dr. Gardner will serve as Chair of the Compensation Committee and as a Member of the Audit Committee and Nominating Committee.
Mr. Greenwood brings substantial expertise in financing pharmaceutical and biotechnology companies. He is Executive Chairman of Corium International, a Menlo Park, California company. He is the former President, Chief Executive Officer, Chief Financial Officer and Director of Geron Corporation.
Mr. Greenwood has served as Chairman of TA Therapeutics, Ltd., a Hong Kong company, as Chairman and a Director of ViaGen, Inc. an Austin, Texas company and a Director of Clone International, a Melbourne, Australia company. From 1979 until 1995, he held various positions with J.P. Morgan & Co. Incorporated, an international banking firm.
Mr. Greenwood holds a B.A. from Pacific Lutheran University and a M.B.A. from Harvard Business School. He will serve as Chair of the Audit Committee and as a Member of the Compensation Committee and Nominating Committee. ■